Trial intelligence / Profile preview

Dapoxetine, Kegel Exercises, and Acupuncture for Premature Ejaculation

NCT07067970Not yet recruiting

Sponsor
Istanbul Medipol University
Start
Oct 2025
Primary completion
Oct 2026
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of dapoxetine in premature ejaculation (PE) (5 arms), sponsored by Istanbul Medipol University. Primary endpoint: Intravaginal Ejaculation Latency Time at Week 16. Planned start Oct 2025; status: not yet recruiting.

02

Drugs

dapoxetine
03

Conditions

premature ejaculation (PE)

Beyond the preview

Go deeper on NCT07067970.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07067970.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call